Hajime Horii

Title: Hajime Horii: Innovator in Antibody Research

Introduction

Hajime Horii is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and genetic engineering techniques. With a total of 3 patents, his work has the potential to impact various medical applications.

Latest Patents

One of Hajime Horii's latest patents is focused on an antibody that exhibits low reactivity with amyloid precursor proteins while demonstrating higher reactivity with amylospheroids. This invention aims to provide an antibody that can inhibit neuronal cell death induced by amylospheroids, which is crucial for addressing neurodegenerative diseases. Another significant patent involves a DNA sequence of the yeast glyceraldehyde-3-phosphate dehydrogenase (GAP-DH) promoter. This innovation simplifies the process of expressing physiologically active substances in yeasts, enhancing the efficiency of DNA recombination.

Career Highlights

Hajime Horii has worked with reputable companies such as the Green Cross Corporation and Tao Health Life Pharma Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in biotechnology.

Collaborations

Throughout his career, Hajime has collaborated with esteemed colleagues, including Haruhide Kawabe and Hirofumi Arimura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hajime Horii's contributions to antibody research and genetic engineering highlight his role as a significant inventor in the biotechnology field. His innovative patents and collaborations continue to pave the way for advancements in medical science.